AQST
Price
$3.01
Change
-$0.05 (-1.63%)
Updated
Feb 21 closing price
Capitalization
383.26M
16 days until earnings call
OPTN
Price
$5.77
Change
-$0.23 (-3.83%)
Updated
Feb 21 closing price
Capitalization
164.47M
11 days until earnings call
Ad is loading...

AQST vs OPTN

Header iconAQST vs OPTN Comparison
Open Charts AQST vs OPTNBanner chart's image
Aquestive Therapeutics
Price$3.01
Change-$0.05 (-1.63%)
Volume$1.42M
Capitalization383.26M
OptiNose
Price$5.77
Change-$0.23 (-3.83%)
Volume$7.53K
Capitalization164.47M
AQST vs OPTN Comparison Chart
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. OPTN commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and OPTN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (AQST: $3.15 vs. OPTN: $5.85)
Brand notoriety: AQST and OPTN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 112% vs. OPTN: 23%
Market capitalization -- AQST: $383.26M vs. OPTN: $164.47M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. OPTN’s [@Pharmaceuticals: Other] market capitalization is $164.47M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileOPTN’s FA Score has 1 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • OPTN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AQST and OPTN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 2 TA indicator(s) are bullish while OPTN’s TA Score has 3 bullish TA indicator(s).

  • AQST’s TA Score: 2 bullish, 6 bearish.
  • OPTN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, OPTN is a better buy in the short-term than AQST.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +6.06% price change this week, while OPTN (@Pharmaceuticals: Other) price change was +6.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +77.53%, and the average quarterly price growth was +51.31%.

Reported Earning Dates

AQST is expected to report earnings on May 13, 2025.

OPTN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AQST($383M) has a higher market cap than OPTN($164M). AQST YTD gains are higher at: -11.517 vs. OPTN (-12.425). AQST has higher annual earnings (EBITDA): 1.18M vs. OPTN (-15.55M). OPTN has more cash in the bank: 73.7M vs. AQST (23.9M). AQST has less debt than OPTN: AQST (33.3M) vs OPTN (132M). OPTN has higher revenues than AQST: OPTN (71M) vs AQST (50.6M).
AQSTOPTNAQST / OPTN
Capitalization383M164M234%
EBITDA1.18M-15.55M-8%
Gain YTD-11.517-12.42593%
P/E RatioN/AN/A-
Revenue50.6M71M71%
Total Cash23.9M73.7M32%
Total Debt33.3M132M25%
FUNDAMENTALS RATINGS
AQST vs OPTN: Fundamental Ratings
AQST
OPTN
OUTLOOK RATING
1..100
1810
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPTN's Valuation (33) in the Medical Or Nursing Services industry is in the same range as AQST (34) in the Pharmaceuticals Major industry. This means that OPTN’s stock grew similarly to AQST’s over the last 12 months.

OPTN's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that OPTN’s stock grew similarly to AQST’s over the last 12 months.

OPTN's SMR Rating (100) in the Medical Or Nursing Services industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that OPTN’s stock grew similarly to AQST’s over the last 12 months.

AQST's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as OPTN (65) in the Medical Or Nursing Services industry. This means that AQST’s stock grew similarly to OPTN’s over the last 12 months.

AQST's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that AQST’s stock grew similarly to OPTN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTOPTN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
82%
Momentum
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

AQST and

Correlation & Price change

A.I.dvisor tells us that AQST and SUPN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQST and SUPN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
-5.12%
SUPN - AQST
26%
Poorly correlated
+1.64%
LFCR - AQST
24%
Poorly correlated
-1.48%
SCYX - AQST
22%
Poorly correlated
-4.46%
ASRT - AQST
22%
Poorly correlated
-3.54%
CAIHF - AQST
21%
Poorly correlated
N/A
More

OPTN and

Correlation & Price change

A.I.dvisor tells us that OPTN and RMTI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTN and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTN
1D Price
Change %
OPTN100%
-2.50%
RMTI - OPTN
25%
Poorly correlated
+2.70%
TXMD - OPTN
21%
Poorly correlated
-0.97%
INDV - OPTN
21%
Poorly correlated
+10.17%
AQST - OPTN
21%
Poorly correlated
-5.12%
SUPN - OPTN
21%
Poorly correlated
+1.64%
More